TALK

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

2020
Kam Dhaliwal, SVP Strategic Alliances, bit.bio
Dr Thomas Moreau, Head of Research, bit.bio
bit.bio talk at ELRIG

 

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

Listen to our talk at the recent ELRIG conference and learn how bit.bio’s opti-ox™ can generate cells with high consistency and functionality at scale from human iPSCs, including those carrying disease-specific mutations, providing high-quality human models for enhanced research outcomes and drug discovery efficiency.

Download resource

Discover more resources

Journals

Posters

Videos

Webinars